Greater China Digest: Biomissile's Series B; Hashkey eyes fu

Biomissile Biopharmaceutical has secured $28.3 million in a Series B round led by Kequan Fund, set up by Anji Economic Development Zone. 

Related Keywords

Deng Chao , Biomissile Biopharma , Anji Economic Development Zone , Fosun Health Capital , Kequan Fund , Bloomberg , Hashkey Group , Anji Economic Development , Key Capital , Hashkey Capital , Hashkey Singapore ,